Design and Procedures
We conducted a prospective cohort study as a sub-study of the Intensified Treatment Monitoring Strategy to Prevent Accumulation of Drug Resistance (ITREMA; Clinicaltrials.gov NCT03357588). ITREMA was an open-label randomized clinical trial evaluating different treatment monitoring strategies for first-line ART, which ran from June 2015 to January 2019 [